Dykema Completes Sale of Assets for TRxADE Health, Inc.

A Dykema team of Peter Waltz, Jon Meulemans, paralegal Jill Knutson, and, Kate Bechen, with the support of other colleagues, helped client TRxADE Health, Inc. (Nasdaq: MEDS) close on the sale of substantially all of the assets of one of its primary operating subsidiaries. Impressively, the Dykema team commenced and closed this deal in under three weeks.

TRxADE Health operates a web-based market platform designed to enable trading among healthcare buyers and sellers of pharmaceuticals, accessories, and services. For this transaction, TRxADE entered into an asset purchase agreement with Micro Merchant Systems, Inc. (MMS), a venture capital-backed company, represented by Kirkland & Ellis.

After completion of the asset sale, TRxADE Health, through a separate wholly owned subsidiary, Integra Pharma Solutions, LLC, will continue to own assets related to, and conduct business as a licensed pharmaceutical wholesaler that sells brand, generic, and non-drug products, and otherwise continue to own its assets that are unrelated to the web-based market platform previously operated by TRxADE Health.